vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and Fathom Holdings Inc. (FTHM). Click either name above to swap in a different company.

Fathom Holdings Inc. is the larger business by last-quarter revenue ($90.6M vs $77.6M, roughly 1.2× Bioceres Crop Solutions Corp.). Fathom Holdings Inc. runs the higher net margin — -7.4% vs -9.6%, a 2.2% gap on every dollar of revenue. On growth, Fathom Holdings Inc. posted the faster year-over-year revenue change (-1.2% vs -16.8%). Over the past eight quarters, Fathom Holdings Inc.'s revenue compounded faster (13.4% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

Fathom Holdings Inc. is a US-based real estate technology and services enterprise. It provides end-to-end solutions for real estate agents, brokers, and consumers, including digital transaction management tools, mortgage services, title insurance, and residential property brokerage services, covering most regional markets across the United States.

BIOX vs FTHM — Head-to-Head

Bigger by revenue
FTHM
FTHM
1.2× larger
FTHM
$90.6M
$77.6M
BIOX
Growing faster (revenue YoY)
FTHM
FTHM
+15.6% gap
FTHM
-1.2%
-16.8%
BIOX
Higher net margin
FTHM
FTHM
2.2% more per $
FTHM
-7.4%
-9.6%
BIOX
Faster 2-yr revenue CAGR
FTHM
FTHM
Annualised
FTHM
13.4%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
FTHM
FTHM
Revenue
$77.6M
$90.6M
Net Profit
$-7.4M
$-6.7M
Gross Margin
46.8%
Operating Margin
9.3%
-5.2%
Net Margin
-9.6%
-7.4%
Revenue YoY
-16.8%
-1.2%
Net Profit YoY
-20.2%
-7.7%
EPS (diluted)
$-0.12
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
FTHM
FTHM
Q4 25
$90.6M
Q3 25
$77.6M
$115.3M
Q2 25
$121.4M
Q1 25
$60.6M
$93.1M
Q4 24
$98.8M
$91.7M
Q3 24
$93.3M
$83.7M
Q2 24
$89.2M
Q1 24
$84.0M
$70.5M
Net Profit
BIOX
BIOX
FTHM
FTHM
Q4 25
$-6.7M
Q3 25
$-7.4M
$-4.4M
Q2 25
$-3.6M
Q1 25
$-1.6M
$-5.6M
Q4 24
$605.2K
$-6.2M
Q3 24
$-6.2M
$-8.1M
Q2 24
$-1.3M
Q1 24
$9.8M
$-5.9M
Gross Margin
BIOX
BIOX
FTHM
FTHM
Q4 25
Q3 25
46.8%
Q2 25
Q1 25
39.4%
Q4 24
42.0%
Q3 24
40.2%
Q2 24
Q1 24
50.8%
Operating Margin
BIOX
BIOX
FTHM
FTHM
Q4 25
-5.2%
Q3 25
9.3%
-3.5%
Q2 25
-2.0%
Q1 25
1.5%
-4.8%
Q4 24
14.5%
-7.0%
Q3 24
2.5%
-9.3%
Q2 24
-4.1%
Q1 24
15.7%
-8.0%
Net Margin
BIOX
BIOX
FTHM
FTHM
Q4 25
-7.4%
Q3 25
-9.6%
-3.8%
Q2 25
-3.0%
Q1 25
-2.6%
-6.1%
Q4 24
0.6%
-6.8%
Q3 24
-6.6%
-9.7%
Q2 24
-1.5%
Q1 24
11.6%
-8.4%
EPS (diluted)
BIOX
BIOX
FTHM
FTHM
Q4 25
$-0.20
Q3 25
$-0.12
$-0.15
Q2 25
$-0.13
Q1 25
$-0.02
$-0.24
Q4 24
$0.00
$-0.29
Q3 24
$-0.10
$-0.40
Q2 24
$-0.07
Q1 24
$0.14
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
FTHM
FTHM
Cash + ST InvestmentsLiquidity on hand
$15.5M
$5.8M
Total DebtLower is stronger
$5.6M
Stockholders' EquityBook value
$288.3M
$37.4M
Total Assets
$734.9M
$78.0M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
FTHM
FTHM
Q4 25
$5.8M
Q3 25
$15.5M
$9.8M
Q2 25
$4.9M
Q1 25
$38.5M
$8.0M
Q4 24
$29.2M
$7.1M
Q3 24
$32.3M
$13.1M
Q2 24
$10.4M
Q1 24
$16.4M
$5.7M
Total Debt
BIOX
BIOX
FTHM
FTHM
Q4 25
$5.6M
Q3 25
$5.1M
Q2 25
$5.1M
Q1 25
$5.1M
Q4 24
$9.5M
Q3 24
$8.8M
Q2 24
$3.6M
Q1 24
$3.7M
Stockholders' Equity
BIOX
BIOX
FTHM
FTHM
Q4 25
$37.4M
Q3 25
$288.3M
$43.4M
Q2 25
$40.7M
Q1 25
$345.0M
$43.4M
Q4 24
$346.3M
$44.7M
Q3 24
$346.0M
$47.1M
Q2 24
$53.1M
Q1 24
$348.5M
$51.9M
Total Assets
BIOX
BIOX
FTHM
FTHM
Q4 25
$78.0M
Q3 25
$734.9M
$83.2M
Q2 25
$80.4M
Q1 25
$798.2M
$81.0M
Q4 24
$835.2M
$75.4M
Q3 24
$827.3M
$80.9M
Q2 24
$80.2M
Q1 24
$836.1M
$78.2M
Debt / Equity
BIOX
BIOX
FTHM
FTHM
Q4 25
0.15×
Q3 25
0.12×
Q2 25
0.12×
Q1 25
0.12×
Q4 24
0.21×
Q3 24
0.19×
Q2 24
0.07×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
FTHM
FTHM
Operating Cash FlowLast quarter
$14.4M
$-20.5M
Free Cash FlowOCF − Capex
$-20.7M
FCF MarginFCF / Revenue
-22.8%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-29.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
FTHM
FTHM
Q4 25
$-20.5M
Q3 25
$14.4M
$3.0M
Q2 25
$-5.9M
Q1 25
$23.3M
$-5.7M
Q4 24
$-5.4M
$-4.7M
Q3 24
$5.2M
$-330.0K
Q2 24
$-3.1M
Q1 24
$-17.4M
$-947.0K
Free Cash Flow
BIOX
BIOX
FTHM
FTHM
Q4 25
$-20.7M
Q3 25
$3.0M
Q2 25
$-6.0M
Q1 25
$-5.8M
Q4 24
$-4.7M
Q3 24
$-364.0K
Q2 24
$-3.1M
Q1 24
$-948.0K
FCF Margin
BIOX
BIOX
FTHM
FTHM
Q4 25
-22.8%
Q3 25
2.6%
Q2 25
-4.9%
Q1 25
-6.2%
Q4 24
-5.2%
Q3 24
-0.4%
Q2 24
-3.5%
Q1 24
-1.3%
Capex Intensity
BIOX
BIOX
FTHM
FTHM
Q4 25
0.1%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
BIOX
BIOX
FTHM
FTHM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-8.85×
Q3 24
Q2 24
Q1 24
-1.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BIOX
BIOX

Segment breakdown not available.

FTHM
FTHM

Real Estate Brokerage$84.9M94%
Mortgage Segment$3.4M4%
Other$2.3M3%

Related Comparisons